Viral dynamics during primary simian immunodeficiency virus infection: Effect of time-dependent virus infectivity

Journal of Virology

Volumn 84, Issue 9, 2010, Pages 4302-4310

  Vaidya, Naveen K ^a   Ribeiro, Ruy M ^a   Miller, Christopher J ^b   Perelson, Alan S ^a  

^a LOS ALAMOS NATIONAL LABORATORY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DONOR; INFECTION RATE; INOCULATION; MONKEY; NONHUMAN; PLASMA; PRIORITY JOURNAL; RECIPIENT; SIMIAN IMMUNODEFICIENCY VIRUS; TIME; VIRUS INFECTION; VIRUS INFECTIVITY; VIRUS ISOLATION; VIRUS LOAD;

ANIMALS; MACACA; MODELS, BIOLOGICAL; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; TIME FACTORS; VIRAL LOAD; VIRULENCE;

ANIMALIA; MACACA; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 77950833850     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.02284-09     Document Type: Article

References (49)

1. Alter, H. J., R. Sanchez-Pescador, M. S. Urdea, J. C. Wilber, R. J. Lagier, A. M. Di Bisceglie, J. W. Shih, and P. D. Neuwald. 1995. Evaluation of branched DNA signal amplification for the detection of hepatitis C virus RNA. J. Viral Hepat. 2:121-132.
2. Althaus, C. L., and R. De Boer. 2008. Dynamics of immune escape during HIV/SIV infection. PLoS Comput. Biol. 4:e1000103.
3. Balamurugan, A., M. J. Lewis, C. M. R. Kitchen, et al. 2008. Primary human immunodeficiency virus type 1 (HIV-1) infection during HIV-1 gag vaccination. J. Virol. 82:2784-2791. (Pubitemid 351329169)
4. Bates, D. M., and D. G. Watts. 2007. Nonlinear regression analysis and its applications. John Wiley & Sons, Inc., Hoboken, NJ.
5. Bourinbaiar, A. S. 1994. The ratio of defective HIV-1 particles to replication- competent infectious virions. Acta Virol. 38:59-61.
6. Burg, D., L. Rong, A. Neumann, and H. Dahari. 2009. Mathematical modeling of viral kinetics under immune control during primary HIV-1 infection. J. Theor. Biol. 259:751-759.
7. Chen, H. Y., M. Di Mascio, A. S. Perelson, D. D. Ho, and L. Zhang. 2007. Determination of virus burst size in vivo using a single-cycle SIV in rhesus macaques. Proc. Natl. Acad. Sci. U. S. A. 104:19079-19098.
8. Ciupe, M. S., B. L. Bivort, D. M. Bortz, and P. W. Nelson. 2006. Estimating kinetic parameters from HIV primary infection data through the eyes of three different mathematical models. Math. Biosci. 200:1-27.
9. Daar, E. S., T. Moudgil, R. D. Meyer, and D. D. Ho. 1991. Transient high levels of viremia in patients with primary human immunodeficiency virus type 1. N. Engl. J. Med. 324:916-964.
10. De Boer, R., and A. S. Perelson. 1998. Target cell limited and immune control models of HIV infection: a comparison. J. Theor. Biol. 190:201-214.
11. Efron, B., and R. Tibshirani. 1986. Bootstrap methods for standard errors, confidence intervals, and other measures of statistical accuracy. Stat. Sci. 1:54-75.
12. Fiebig, E. W., D. J. Wright, B. D. Rawal, P. E. Garrett, R. T. Schumacher, L. Peddada, C. Heldebrant, R. Smith, A. Conrad, S. H. Kleinman, and M. P. Busch. 2003. Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection. AIDS 17:1871-1879.
13. Fox, J., J. Weber, and S. Fidler. 2006. Primary HIV. Sex. Transm. Infect. 82:267-268.
14. Goonetilleke, N., M. K. P. Liu, J. F. Salazar-Gonzelez, G. Ferrari, E. Giorgi, V. Ganusov, B. F. Keele, G. H. Learn, E. L. Turnbull, M. G. Salazar, K. J. Weinhold, S. Moore, B. N. Letvin, B. F. Haynes, M. S. Cohen, P. Hraber, T. Bhattacharya, P. Borrow, A. S. Perelson, B. H. Hahn, G. M. Shaw, B. T. Korber, A. J. McMichael, et al. 2009. The first T-cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infection. J. Exp. Med. 206:1252-1272.
15. Haaft, P., N. Almond, G. Biberfeld, A. Cafaro, M. Cranage, B. Ensoli, G. Hunsmann, N. Polyanskaya, C. Stahl-Hennig, R. Thortensson, F. Titti, and J. Heeney. 2001. Comparison of early plasma RNA loads in different macaque species and the impact of different routes of exposure on SIV/SHIV infection. J. Med. Prematol. 30:207-214.
16. Hijikata, M., Y. K. Shimizu, H. Kato, A. Iwamoto, J. W. Shih, H. J. Alter, R. H. Purcell, and H. Yoshikura. 1993. Equilibrium centrifugation studies of hepatitis C virus: evidence for circulating immune complexes. J. Virol. 67: 1953-1958. (Pubitemid 23088368)
17. Jin, X., D. E. Bauer, S. E. Tuttleton, S. Lewin, A. Gettie, J. Blanchard, C. E. Irwin, J. T. Safrit, J. Mittler, L. Weinberger, L. Kostrikis, L. Zhang, A. S. Perelson, and D. D. Ho. 1999. Dramatic rise in plasma viremia after CD8+ T-cell depletion in simian immunodeficiency virus infected macaques. J. Exp. Med. 189:991-998.
18. Katayama, K., J. Kumagai, Y. Komiyo, M. Mizui, H. Yugi, S. Kishimoto, R. Yamanaka, S. Tamatsukuri, T. Tomoguri, Y. Miyakawa, J. Tanaka, and H. Yoshizawa. 2004. Titration of hepatitis C virus in chimpanzees for determining the copy number required for transmission. Intervirology 47:57-64. (Pubitemid 38420868)
19. Keele, B. F., H. Li, G. H. Learn, P. Hraber, et al. 2009. Low-dose rectal inoculation of rhesus macaques by SIVsmE660 or SIVmac251 recapitulates human mucosal infection by HIV-1. J. Exp. Med. 206:1117-1134.
20. Komiya, Y., K. Katayama, H. Yugi, M. Mizui, H. Matsukura, T. Tomoguri, Y. Miyakawa, A. Tabuchi, J. Tanaka, and H. Yoshizawa. 2008. Minimum infectious dose of hepatitis B virus in chimpanzees and difference in the dynamics of viremia between genotype A and genotype C. Transfusion 48:286-294.
21. Koopman, J. S., J. A. Jacquez, G. W. Welch, C. P. Simon, B. Foxman, S. M. Pollock, D. Barth-Jones, A. L. Adams, and K. Lange. 1997. The role of early HIV infection in the spread of HIV through populations. J. Acquir. Immune Defic. Syndr. Hum. Retrovir. 14:249-258.
22. Kwon, Y. J., G. Hung, W. E. Anderson, C. A. Peng, and H. Yu. 2003. Determination of infectious retrovirus concentration from colony-forming assay with quantitative analysis. J. Virol. 77:5712-5720.
23. Levy, J. A., C. E. Mackewicz, and E. Barker. 1996. Controlling HIV pathogenesis: the role of noncytotoxic anti-HIV activity of CD8 cells. Immunol. Today 17:217-224.
24. + T cells. Nature 434:1148-1152.
25. Little, S. J., A. R. McLean, C. A. Spina, D. D. Richman, and D. V. Havlir. 1999. Viral dynamics of acute HIV-1 infection. J. Exp. Med. 190:141-150.
26. Ma, Z., M. Stone, M. Piatak, B. Schweighardt, N. L. Haigwood, D. Monte- fiori, J. D. Lifson, M. Busch, and C. J. Miller. 2009. High specific infectivity of plasma virus from the pre-ramp and ramp up stages of acute simian immunodeficiency virus infection. J. Virol. 83:3288-3297.
27. Macey, R. I., and G. F. Oster. 2001. Berkeley Madonna, version 8.0. University of California at Berkeley, Berkeley, CA.
28. + cell noncytotoxic anti-human immunodeficiency virus response inhibits expression of viral RNA but not reverse transcription or provirus integration. J. General Virol. 81:1261-1264.
29. Markowitz, M., M. Louie, A. Hurley, E. Sun, M. Di Mascio, A. S. Perelson, and D. D. Ho. 2003. A novel antiviral intervention results in more accurate assessment of human immunodeficiency virus type 1 replication dynamics and T-cell decay in vivo. J. Virol. 77:5037-5038.
30. Marozsan, A. J., E. Fraundorf, A. Abraha, H. Baird, D. Moore, R. Troyer, I. Nankja, and E. J. Arts. 2004. Relationships between infectious titer, capsid protein levels, and reverse transcriptase activities of diverse human immunodeficiency virus type 1 isolates. J. Virol. 78:11130-11141.
31. Miller, C. J., Q. Li, K. Abel, E. Y. Kim, Z. M. Ma, S. Wietgrefe, L. La Franco-Scheuch, L. Compton, L. Duan, M. D. Shore, M. Zupancic, M. Busch, J. Carlis, S. Wolinsky, and A. T. Haase. 2005. Propagation and dissemination of infection after vaginal transmission of simian immunodeficiency virus. J. Virol. 79:9217-9227. (Pubitemid 40934833)
32. Murray, J. M., G. Kaufmann, A. D. Kelleher, and D. A. Cooper. 1998. A model of primary HIV-1 infection. Math. Biosci. 154:57-85.
33. Nowak, M. A., A. L. Lloyd, G. M. Vasquez, et al. 1997. Viral dynamics of primary viremia and antiretroviral therapy in simian immunodeficiency virus infection. J. Virol. 71:7518-7525.
34. Perelson, A. S., P. Essunger, Y. Cao, M. Vesanen, A. Hurley, K. Saksela, M. Markowitz, and D. D. Ho. 1997. Decay characteristics of HIV-1-infected compartments during combination therapy. Nature 387:188-191.
35. Perelson, A. S., and P. W. Nelson. 1999. Mathematical analysis of HIV-1 dynamics of vivo. SIAM Rev. 41:3-44.
36. Phillips, A. N. 1996. Reduction of HIV concentration during acute infection: independence from a specific immune response. Science 271:497-499.
37. Pilcher, C. D., H. C. Tien, J. J. Eron, et al. 2004. Brief but efficient: acute HIV infection and the sexual transmission of HIV. J. Infect. Dis. 189:1785-1792.
38. Platt, E. J., S. L. Kozak, J. P. Durnin, T. J. Hope, and D. Kabat. 2010. Rapid dissociation of HIV-1 from cultured cells severely limits infectivity assays, causes the inactivation ascribed to entry inhibitors, and masks the inherently high infectivity of virions. J. Virol. 84:3106-3110.
39. Pope, M., and A. T. Haase. 2003. Transmission, acute HIV-1 infection and the quest for strategies to prevent infection. Nat. Med. 9:847-852.
40. Price, D. A., P. J. R. Goulder, P. Klenerman, A. K. Sewell, P. J. Easter-brook, M. Troop, C. R. M. Bangham, and R. E. Phillips. 1997. Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infection. Proc. Natl. Acad. Sci. U. S. A. 94:1890-1895.
41. Ramratnam, B., S. Bonhoeffer, J. Binley, A. Hurley, L. Zhang, J. E. Mittler, M. Markowitz, J. P. Moore, A. S. Perelson, and D. D. Ho. 1999. Rapid production and clearance of HIV-1 and hepatitis C virus assessed by large volume plasma apheresis. Lancet 354:1782-1785.
42. Rusert, P., M. Fischer, B. Joos, C. Leemann, H. Kuster, M. Flepp, S. Bonhoeffer, H. F. Gunthard, and A. Trkola. 2004. Quantification of infectious HIV-1 plasma viral load using a boosted in vitro infection protocol. Virology 326:113-129. (Pubitemid 38943011)
43. Schacker, T., A. Collier, J. Hughes, T. Shea, and L. Corey. 1996. Clinical and epidemiologic features of primary HIV infection. Ann. Intern. Med. 125: 257-264.
44. Stafford, M. A., L. Corey, Y. Cao, E. S. Daar, D. D. Ho, and A. S. Perelson. 2000. Modeling plasma virus concentration during primary HIV infection. J. Theor. Biol. 203:285-301.
45. Tabuchi, A., J. Tanaka, K. Katayama, M. Mizui, H. Matsukura, H. Yugi, T. Shimada, Y. Miyakawa, and H. Yoshizawa. 2008. Titration of hepatitis B virus infectivity in the sera of pre-acute and late acute phases of HBV infection: transmission experiments to chimeric mice with human liver repopulated hepatocytes. J. Med. Virol. 80:2064-2068.
46. Tuckwell, H. C., P. D. Shipman, and A. S. Perelson. 2008. The probability of HIV infection in a new host and its reduction with microbicides. Math. Biosci. 214:81-86.
47. Veazey, R. S., and A. A. Lackner. 2004. Getting to the guts of HIV pathogenesis. J. Exp. Med. 200:697-700.
48. Wawer, M. J., R. H. Gray, N. K. Sewankambo, D. Serwadda, X. Li, O. Laeyendecker, N. Kiwanuka, G. Kigozi, M. Kiddugavu, T. Lutalo, F. Nalugoda, F. Wabwire-Mangen, M. P. Meehan, and T. C. Quinn. 2005. Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda. J. Infect. Dis. 191:1403-1409.
49. Zhang, L., P. J. Dailey, A. Gettie, J. Blanchard, and D. D. Ho. 2002. The liver is a major organ for clearing simian immunodeficiency virus in rhesus monkeys. J. Virol. 76:5271-5273.